C7H14ClNO
163.64 g/mol
Pharmaceutical IntermediateWarning
Endo-8-Azabicyclo[3.2.1]octan-3-ol hydrochloride
CAS14383-51-8EC238-356-6
Category
Pharmaceutical Intermediate
Compound Class
Alcohol
Primary Use
Pharmaceutical Intermediate
endo-8-Azabicyclo[3. 2.
pharmaceutical intermediate
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Endo-8-Azabicyclo[3.2.1]octan-3-ol hydrochloride?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Related Compounds
ReferenceSame Category
9-bromo-3-(2-bromoacetyl)-10,11-dihydro-5H-dibenzo[c,g]chromen-8(9H)-one
CAS1438383-89-1
pharmaceutical intermediate
ReferenceSame Category
3-acetyl-10,11-dihydro-5H-dibenzo[c,g]chromen-8(9H)-one
CAS1438383-92-6
pharmaceutical intermediate
ReferenceSame Category
6-(Phthalimidomethyl)-6,11-dihydro-5H-dibenz[b,e]azepine
CAS143878-20-0
pharmaceutical intermediate
ReferenceSame Category
(R)-1-Boc-3-Hydroxypiperidine
CAS143900-43-0
pharmaceutical intermediate
Referencestereoisomer of
Nortropine
CAS538-09-0
research compound
Referencesame scaffold
N-Isopropylnortropine
CAS3423-25-4
pharmaceutical intermediate
Referencesame scaffold
8-Methyl-8-azabicyclo[3.2.1]octan-3-amine dihydrochloride
CAS646477-45-4
pharmaceutical intermediate
Referencesame scaffold
8-Methyl-8-azabicyclo[3.2.1]octan-3-amine
CAS98998-25-5
research compound
Safety Reference
Warning
H302Harmful if swallowed
H312Harmful in contact with skin
H332Harmful if inhaled
Identifiers
IUPAC Name
8-azabicyclo[3.2.1]octan-3-ol;hydrochloride
InChIKey
RROJVSOIIWHLCQ-UHFFFAOYSA-N
SMILES
C1CC2CC(CC1N2)O.Cl
Synonyms (13)
- Nortropine HCl
- Nortropine Impurity 1 HCl
- Nortropine hydrochloride
Sourcing Endo-8-Azabicyclo[3.2.1]octan-3-ol hydrochloride?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.